ArticleMedical oncology (Northwood, London, England)2026

CD168 in lung adenocarcinoma: prognostic relevance, immune feature associations, and MAPK/ERK pathway enrichment.

Meihan Liu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.